PFIZER

Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world and their products are pharmaceutical drugs, vaccines.

As om 2021, Pfizer has 79,000 employees.

Pfizer annual revenue generated for period ending Dec-2021 was 81.28 million USD.

Pfizer annual net income generated for period ending Dec-2021 was 21.98 million USD.

Total Assets as on Dec-2021 was 181,476 Million USD

Major Acquisitions

Pfizer acquired Wyeth for 68 Billion USD in 2009.

Annual Results Summary:

Pfizer Inc - Yearly Revenue and Net Profit - in Billion USD:

Year - Ending	Revenue	Operating Income	Net Profit
Dec-2022	100.33	37.27	31.37
Dec-2021	81.28	23.65	21.98
Dec-2020	41.91	8.76	9.62
Dec-2019	51.75	13.92	16.27
Dec-2018	53.65	15.04	11.15
Dec-2017	52.54	14.10	21.31
Dec-2016	52.82		7.21

Balance Sheet Summary

Pfizer Inc - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2022	197,205	101,289	95,916
Dec-2021	181,476	104,014	77,462
Dec-2020	154,229	90,991	63,238
Dec-2019	167,489	104,345	63,143
Dec-2018	159,422	96,015	63,407
Dec-2017	171,797	100,489	71,308
Dec-2016	171,615	112,072	59,544

Quarterly Results Summary:

Pfizer Inc - Quarterly Revenue and Net Profit - in Million USD:

Quarter - Ending	Revenue	Net Profit
Dec-2022	24,290	4,995
Sep-2022	22,638	8,608
Jun-2022	27,742	9,906
Mar-2022	25,661	7,864
Dec-2021	23,838	3,393
Sep-2021	24,094	8,146
Jun-2021	18,977	5,589
Mar-2021	14,582	4,886
Dec-2020	5,947	630
Sep-2020	12.13	2.19
Jun-2020	11.80	3.42
Mar-2020	12.03	3.40
Dec-2019	12.69	(-)0.33 (Loss)
Sep-2019	12.68	7.68
Jun-2019	13.26	5.05
Mar-2019	13.12	3.88
Dec-2018	13.98	(-)0.39 (Loss)
Sep-2018	13.30	4.11
Jun-2018	13.47	3.87

Institutional Investors

Top 30 Institutional Investors in PFIZER as on JUN-30-2022

RANK	INSTITUTIONAL HOLDER NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	6/30/2022	488,445,127	9,379,854	1.96%	$22,439,169
2	BLACKROCK INC.	6/30/2022	435,152,528	27,068,406	6.63%	$19,990,907
3	STATE STREET CORP	6/30/2022	287,217,028	362,823	0.13%	$13,194,750
4	CAPITAL WORLD INVESTORS	6/30/2022	250,126,747	30,250,912	13.76%	$11,490,823
5	WELLINGTON MANAGEMENT GROUP LLP	6/30/2022	219,171,647	2,497,346	1.15%	$10,068,745
6	GEODE CAPITAL MANAGEMENT, LLC	6/30/2022	108,582,838	3,684,436	3.51%	$4,988,296
7	MORGAN STANLEY	6/30/2022	72,548,435	25,173,688	53.14%	$3,332,875
8	NORTHERN TRUST CORP	6/30/2022	66,978,348	467,468	0.70%	$3,076,985
9	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	6/30/2022	64,122,012	4,293,163	7.18%	$2,945,765
10	BANK OF AMERICA CORP /DE/	6/30/2022	61,777,210	2,779,143	4.71%	$2,838,045
11	NORGES BANK	12/31/2021	56,763,604	-2,124,201	-3.61%	$2,607,720
12	BANK OF NEW YORK MELLON CORP	6/30/2022	56,341,321	1,708,092	3.13%	$2,588,320
13	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	6/30/2022	53,568,997	0	0%	$2,460,960
14	CAPITAL INTERNATIONAL INVESTORS	6/30/2022	49,430,982	10,900,979	28.29%	$2,270,859
15	LEGAL & GENERAL GROUP PLC	6/30/2022	42,791,672	1,336,403	3.22%	$1,965,849
16	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	6/30/2022	42,257,600	-1,133,519	-2.61%	$1,941,314
17	JPMORGAN CHASE & CO	6/30/2022	41,031,975	7,981,650	24.15%	$1,885,009
18	DIMENSIONAL FUND ADVISORS LP	6/30/2022	40,233,015	1,331,272	3.42%	$1,848,305
19	DEUTSCHE BANK AG\	6/30/2022	39,132,177	673,414	1.75%	$1,797,732
20	PRICE T ROWE ASSOCIATES INC /MD/	6/30/2022	34,938,210	-404,839	-1.15%	$1,605,061
21	AMUNDI	6/30/2022	27,789,344	2,149,041	8.38%	$1,276,642
22	UBS ASSET MANAGEMENT AMERICAS INC	6/30/2022	25,979,571	1,820,095	7.53%	$1,193,501
23	ROYAL BANK OF CANADA	6/30/2022	25,361,302	-1,593,788	-5.91%	$1,165,098
24	SWISS NATIONAL BANK	6/30/2022	24,393,441	82,500	0.34%	$1,120,635
25	WELLS FARGO & COMPANY/MN	6/30/2022	22,899,251	-2,131,535	-8.52%	$1,051,992
26	AMERIPRISE FINANCIAL INC	6/30/2022	22,053,718	-560,926	-2.48%	$1,013,148
27	PARAMETRIC PORTFOLIO ASSOCIATES LLC	3/31/2022	21,908,327	217,479	1.00%	$1,006,469
28	GOLDMAN SACHS GROUP INC	6/30/2022	21,865,861	2,033,150	10.25%	$1,004,518
29	FMR LLC	6/30/2022	20,724,644	2,935,073	16.50%	$952,090
30	NUVEEN ASSET MANAGEMENT, LLC	6/30/2022	20,629,500	13,528	0.07%	$947,719

Comments

Pfizer is expanding Phase 3 Trials to test Covid-19 Vaccine

Pfizer and BioNTech planning to expand phase 3 trials to test Covid-19 vaccine. From initial plan of 30,000 people, now they are planning to conduct trials of Covid-19 vaccine on 44,000 people. They are expecting results by Oct-2020 ending.

Sun, 13/09/2020 - 14:58